Clinical Trials Logo

Metastases to Perineum clinical trials

View clinical trials related to Metastases to Perineum.

Filter by:
  • None
  • Page 1

NCT ID: NCT01471132 Recruiting - Gastric Cancer Clinical Trials

Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis

SHOP-G01
Start date: September 2011
Phase: Phase 2
Study type: Interventional

The recurrence and metastasis of peritoneum is always the lethal consequence for gastric cancer patients, and there is no effective therapy until now. It has been reported by Dr.Fujimoto that intraperitoneal chemotherapy plus hyperthermic therapy, which called hyperthermic intraperitoneal chemotherapy (HIPEC), can eliminate and suppress the free cancer cells and tiny metastasis in abdomen. Refer to the experience of systematic chemotherapy, HIPEC with combination regimen would have a brighter prospect. In this study, the investigators would use Oxaliplatin and paclitaxel sequent as HIPEC regimen. The safety and overall survival would be observed and evaluated.